Please login to the form below
UAE
This page shows the latest UAE news and features for those working in and with pharma, biotech and healthcare.
China’s Sinopharm given WHO emergency use listing for COVID-19 vaccine
Sinopharm previously reported that the vaccine has a ‘protective efficacy’ against COVID-19 of 79.34%, based on results from phase 3 clinical trial that took place across China, UAE and
Latest news
-
Trial combining British and Russian COVID-19 vaccines could begin in February
Repik added that the trials are set to be conducted in Azerbaijan, Argentina, Saudi Arabia, the UAE, Belarus, Russia and other locations.
-
Sinopharm’s COVID-19 vaccine scores approval in China
The vaccine has been granted a conditional marketing approval, after 60, 000 volunteers took part in phase 3 clinical trials across China, UAE and Bahrain. ... the 86% efficacy rate announced by UAE and 79.34% by China are both real and valid”.
-
World Diabetes Day 2019
The survey, undertaken for Merck by YouGov between 14-22 October 2019, included 9, 350 participants across nine countries (Brazil, Mexico, Russia, UAE, Malaysia, Vietnam, China, Saudi Arabia and Chile).
-
Hanover launches Middle East office in Dubai
Operations will be led by Jonty Summers. Hanover has opened up a new office in the Middle East following its appointment to a number of ‘high-profile’ projects in the UAE.
-
The Netherlands leads Europe for future health
It was placed second only to the United Arab Emirates (UAE), which took first place in the global Future Health Index rankings. ... Driven by a perceived strength in accessible and integrated care, and a high interest in online interactions and digital
More from news
Approximately 1 fully matching, plus 13 partially matching documents found.
Latest Intelligence
-
Deal Watch table for May 2013
UAE based regional company $40m $244m option for 52%. 284. Inviragen/ Takeda.
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
Create, captivate and communicate: Cogent, a new full-service healthcare communications agency joins the AMICULUM® family
Hong Kong, Singapore, UAE, Switzerland, the UK and the USA.
-
AMICULUM® launches Cence, a new specialist publications agency
Hong Kong, Singapore, UAE, Switzerland, the UK and the USA.
-
AMICULUM® launches new specialist agency: AMICULUM Access
AMICULUM has teams based in NZ, China, Singapore, UAE, Switzerland, the UK and USA.
-
AMICULUM boosts global healthcare communications offering with a new specialist agency, Seques®
Singapore, UAE, Switzerland, UK and the USA.
-
Four Communications acquires Healthcare specialist MSA Media
The Group now has operations in London, Edinburgh and Cardiff in the United Kingdom and in Abu Dhabi and Dubai in the UAE.
More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Bristol Myers Squibb announces positive trial results for treatment of MS
- My journey advancing the science in pulmonary hypertension
- NHS App to revolutionise digital health and care with major digital updates by 2023
- A new era for UK-Japanese scientific research relations
- Innovative Health Initiative launches first two calls for proposals to tackle ‘biggest’ health research challenges
- Pfizer and BioNTech share positive results for Omicron-adapted COVID-19 vaccine
- New Omicron sub-variants cause COVID-19 cases to rise in the UK
- Novartis announces positive phase 3 trial results for advanced oesophageal cancer
- Sanofi Global Health unveils new nonprofit Impact brand
- Pfizer announces commitment to achieve Net-Zero Standard by 2040
- NICE issues final draft recommending Novartis’ Scemblix to treat chronic myeloid leukaemia
- Alzheimer's Research UK supports government plans for clinical research
- A creative awakening – how pharma is bringing innovation to the patient journey
- Behaviour change – a maze of decisions influenced by personal habits, experiences and intentions
- My journey advancing the science in pulmonary hypertension
- Pfizer and BioNTech share positive results for Omicron-adapted COVID-19 vaccine
- Novartis publishes final positive phase 3 results of Zolgensma in Nature Medicine
- Delivering content to fuel omnichannel engagement
PMHub
Impetus Digital
Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education...
Latest intelligence
- Our Top 5 Pharma Picks From Cannes Lions
- Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
- The Evolving Role of the Sales Rep
- The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
- Measure your omnichannel maturity with our new tool
- Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
